127 filings
Page 4 of 7
8-K
ojy2z43viwr94kgafe
14 May 20
Ritter Pharmaceuticals, Inc. Announces Adjournment of its Special Meeting
5:12pm
8-K
3eh b51z3mt7ui
11 May 20
Other Events
8:03am
8-K
sxd8y1orm6c6gdjrtb
1 May 20
Form S-4 Declared Effective by the SEC and Ritter/Qualigen Merger Voting is Underway
5:29pm
8-K
cckum567fq
16 Apr 20
Ritter Pharmaceuticals, Inc. Announces Form S-4
4:07pm
8-K
gmx5s6gcca 4p9w
31 Mar 20
Definitive merger agreement with Qualigen, Inc. announced in January 2020
5:29pm
8-K
0ds 9rrqdk9
11 Mar 20
Entry into a Material Definitive Agreement
8:32am
8-K
9mxck91 dbrbhm3j4
3 Mar 20
Other Events
6:17am
8-K
olz5lnx mqc1df
21 Feb 20
Entry into a Material Definitive Agreement
7:52am
8-K
7sdecanh
7 Feb 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
nsaan3
21 Jan 20
Ritter Pharmaceuticals, Inc. and Qualigen, Inc. Announce Merger Agreement
9:20am
8-K
6i6mzc 0ihfd
26 Nov 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9:00am
8-K
7zn1koijuvodfirf0t
13 Nov 19
Results of Operations and Financial Condition
9:25pm
8-K
m1iy f99qssbexok25
6 Nov 19
Entry into a Material Definitive Agreement
9:56pm
8-K
4xahuvsz053p570qzxe
1 Nov 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K
0z2go tcead3y0yuon
15 Oct 19
Departure of Directors or Certain Officers
4:15pm
8-K
micwz7eunjty
18 Sep 19
Departure of Directors or Certain Officers
5:27pm
8-K
y32as6
12 Sep 19
Ritter Pharmaceuticals Reports Top-Line Results from its Liberatus Phase 3 Trial of RP-G28 for Lactose Intolerance
4:30pm
8-K
ryyeolg
23 Aug 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
cc76r43mbxpur nz
14 Aug 19
Results of Operations and Financial Condition
12:00am
8-K
dz1me 5w2
24 Jul 19
Entry into a Material Definitive Agreement
5:29pm